Home Newsletters Industry News

Industry News

Random

Ligand’s Partner Travere Therapeutics Announces Confirmatory Data from the Phase 3 PROTECT Study of FILSPARI® Demonstrating Long-Term Kidney Function Preservation in IgA Nephropathy; Narrowly...

Admin - September 21, 2023

Septerna Announces Novel GPCR-targeted Program Acquired by Vertex

Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate

Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO® (mogamulizumab) at EORTC 2023.

GSK Announces AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Is Now Available at All Major US Retail Pharmacies

ARMGO Pharma Enrolls First Patient in Phase 2 Trial of ARM210...

Admin - July 19, 2023 0

Aurinia Files Form S-8 to Register Shares Underlying Previously Disclosed Inducement...

Admin - May 28, 2023 0

Autobahn Therapeutics Completes Dosing in its Phase 1 Multiple-ascending Dose Study...

Admin - September 11, 2023 0

Amneal Launches Authorized Generic for XyremÂ® (sodium oxybate) and Receives FDA...

Admin - July 3, 2023 0

Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279,...

Admin - September 11, 2023 0

Merck and Eisai Provide Update on Two Phase 3 Trials Evaluating...

Admin - September 22, 2023 0

Anokion Announces Clinical Progress with KAN-101 and ANK-700

Admin - September 12, 2023 0

NextGen Healthcare and Luma Health Announce Strategic Alliance to Offer AI-Enhanced...

Admin - August 24, 2023 0

Pipeline Therapeutics Announces First Subject Dosed with PIPE-791 in Phase 1...

Admin - August 1, 2023 0

Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show Durable, Long-Term...

Admin - September 11, 2023 0

12 3...18 Page 1 of 18